Одну секунду
Что-то сучилось. Попробуйте еще раз.
PAH смотреть последние обновления за сегодня на .
Watch this video to learn more about what pulmonary arterial hypertension (PAH) is. #WithYouUntilPHIsnt
Pulmonary arterial hypertension (PAH) is a rare, progressive disorder caused when the tiny arteries in your lungs become thickened and narrowed. Hear Lindsay’s story about how she is successfully living her life with PAH. Support for this educational campaign is provided by Janssen. Learn more at Lung.org/PAH.
PAH is a silently progressive, deadly disease. Discover how it can progress from a disease affecting the structure of the pulmonary arteries up to right heart failure.
Pulmonary Arterial Hypertension (PAH) is a specific type of pulmonary hypertension that is caused when the tiny arteries in your lung become thickened and narrowed. It is a rare, progressive lung disease, most common in women between the ages of 30-60 but can affect people of all ages. The American Lung Association is collaborating with Janssen to share new resources about PAH. Learn more at Lung.org/PAH.
Gustavo A. Heresi, MD, MS, Director of the Pulmonary Vascular and Chronic Thromboembolic Pulmonary Hypertension Program in the Department of Pulmonary and Critical Care Medicine in the Respiratory Institute at Cleveland Clinic discusses the challenges of diagnosing and treating patients with pulmonary arterial hypertension (PAH). PAH is a rare, progressive disorder characterized by high blood pressure (hypertension) in the arteries of the lungs (pulmonary artery) for no apparent reason. The pulmonary arteries are the blood vessels that carry blood from the right side of the heart through the lungs. Symptoms of PAH include shortness of breath (dyspnea) especially during exercise, chest pain, and fainting episodes. The exact cause of PAH is unknown and although treatable, there is no known cure for the disease. PAH usually affects women between the ages of 30-60. The progressive nature of this disease means that an individual may experience only mild symptoms at first, but will eventually require treatment and medical care to maintain a reasonable quality of life. Advances in the diagnosis and management of PAH have resulted in significant improvements in outcomes for patients with this devastating and progressive disease. However, because of the non-specific nature of its symptoms, and the low level of suspicion among clinicians, prompt and accurate diagnosis of PAH as a rare disease remains a challenge. This article explains some of the issues that need to be addressed when faced with a patient with suspected PAH and describes how noninvasive and invasive techniques can be used effectively to ensure an accurate diagnosis.
From the time they were diagnosed with pulmonary arterial hypertension (PAH) until now, PAH Initiative Ambassadors Joanne and Laura, have learned a lot. In this short video, they share what they wish they had known at diagnosis in hopes of helping others.
Pulmonary arterial hypertension (PAH) is a progressive, irreversible disease that is frequently delayed in diagnosis and treatment. Watch to learn more about initiating combination therapy in patients with PAH. More content about PAH is available for AMA PRA Category 1 Credit(s)™ Watch the Webinar ➤ 🤍 View the Activity ➤ 🤍 Pulmonary Arterial Hypertension Playlist ➤ 🤍 This video is supported by an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson. Developed for physicians and advance practice providers.
Are you able to diagnose Pulmonary Arterial Hypertension in your patients? PAH is often misdiagnosed, resulting in patients experiencing years of delayed accurate diagnosis. Watch this documentary and hear from leading clinicians and patients on their experiences. Learn more at: 🤍
Meet John, Amina and Irena. They all live with pulmonary arterial hypertension (PAH), a rare form of pulmonary hypertension (PH), and share their personal stories in this video. John, Amina and Irena have all had different experiences of living with PAH, and in this video we explore their diagnosis, symptoms and helpful tips to adjust to a life with PAH. To hear more personal stories from people adjusting to life with PAH, visit our PH Human website. 🤍
Meet An and Sussie. They both live with pulmonary arterial hypertension (PAH), a rare form of pulmonary hypertension (PH), and share their personal stories in this video. In this video we hear about their unique paths to their PAH diagnoses, and their advice for newly diagnosed patients, such as finding support from a local patient organisation and talking with other patients about living with PAH. To hear more personal stories from people living with PAH, visit our PH Human website: 🤍 What is PH? Pulmonary hypertension (PH) is high pressure in the blood vessels of the lungs, as the right side of the heart has to work harder to pump blood through the lungs.1,2 It is a serious, progressive disease and can lead to heart failure and early death.3,4 Pulmonary arterial hypertension (PAH) is a progressive, rare type of PH that affects the blood vessels that carry blood from the heart to the lungs.2,5 These are known as pulmonary arteries.2,5 Over time, the pulmonary arteries become increasingly narrow, as the walls of the blood vessels become thicker and less flexible.2,5 This restricts blood flow to the lungs, which makes it harder for the heart to pump blood through the arteries.6 Trying to maintain the blood flow, the heart has to pump harder, increasing the pressure in the pulmonary arteries.6 Due to the rarity of PAH and the non-specific nature of its symptoms, PAH can be confused with more common conditions such as chronic obstructive pulmonary disease (COPD).3,4 References 1. Galiè N, Humbert M, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016;37:67–119. 2. Lai Y, Potoka KC, et al. Pulmonary arterial hypertension: The clinical syndrome. Circ Res 2014;115:115–30. 3. Vachiéry JL and Gaine S. Challenges in the diagnosis and treatment of pulmonary arterial hypertension. Eur Respir Rev 2012;21:313–20. 4. Hoeper MM and Gibbs SR. The changing landscape of pulmonary arterial hypertension and implications for patient care. Eur Respir Rev 2014;23:450–7. 5. Schermuly RT, Ghofrani HA, et al. Mechanisms of disease: Pulmonary arterial hypertension. Nat Rev Cardiol 2011;8:443–55. 6. National Organisation of Rare Diseases (2019). Rare Disease Database: Pulmonary Arterial Hypertension. Available at: 🤍
AMA/ANCC/ACPE Activity - Lecture Library Slide Set Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension (PAH). Slides are developed and updated throughout the year by leading PAH expert physicians. All content is reviewed and approved by the Simply Speaking PAH Planning Committee. PAH is characterized by increased pulmonary vascular resistance due to remodeling and occlusion of the pulmonary arterioles, resulting in right heart failure and death within 2-3 years of diagnosis if untreated. Despite advances in the diagnosis and treatment of PAH over the last two decades, the prognosis is still poor. Early recognition of disease, institution of effective PAH disease-specific therapy optimized for disease severity, and comprehensive care in specialized centers hold the promise of improving the outcome of patients. PAH is often misdiagnosed or unrecognized in clinical practice and delaying treatment options can worsen outcomes and survival. Diagnostic tests are needed to be done on anyone with unexplained dyspnea and suspected PAH. This on-demand presentation is designed using a case-based, interactive discussion on tools to improve the diagnosis of PAH and the importance of early referral. FACULTY Jean Elwing, MD Professor of Medicine Director, Pulmonary Hypertension Program University of Cincinnati Review the activity at 🤍 and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation. This activity is jointly provided by the University of Nebraska Medical Center, Duquesne University School of Pharmacy and Practice Point Communications Supported by independent educational grants from United Therapeutics Corporation, Bayer U.S. and Actelion Pharmaceuticals U.S., Inc., A Janssen Pharmaceutical Company of Johnson & Johnson #freecme #pah #pulmonaryhypertension #practicepointcme
Living with pulmonary arterial hypertension (PAH) can be a big adjustment and taking care of yourself can make a big difference. But where do you start? Watch this short video to hear from Gwen, Joanne, and Lauren about their approaches to self-care and healthy living with PAH.
Meet Chloe, a singer and performer who was diagnosed with pulmonary arterial hypertension (PAH), which is a rare form of pulmonary hypertension (PH). In this video, we explore how Chloe has learned to adjust to living with PAH following her diagnosis. This includes following advice from her healthcare team as well as ensuring she plays a proactive role in her condition by developing five key principles that she lives by, from eating well to making time for family and friends. To hear more personal stories from people adjusting to life with PAH, PH Human website. 🤍
This video shows the signs and symptoms of PAH and clearly illustrates what causes them. Once a patient has persistent signs and symptoms, more testing is needed. It stresses the importance of friends and family along with a specialized team of healthcare professionals to support the patient along the journey to diagnosis.
AMA/ANCC/ACPE Activity Talking PAH is a webcast series that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and presented by leading PAH expert physicians and further reviewed and approved by the planning committee. Pulmonary arterial hypertension (PAH) is a progressive and fatal lung disease of multifactorial etiology. Currently, therapies for treating pulmonary hypertension have been used alone and in combination to demonstrate improvements in quality of life and hemodynamic parameters as well as in slowing disease progression; however, beneficial effects on survival are limited. None offer a cure against PAH nor directly address the underlying cellular proliferation that leads to increased pulmonary arterial pressure, and the median survival rate remains at 61% at five years after diagnosis. Extensive research efforts have led to the emergence of innovative therapeutic approaches in PAH. This on-demand webcast focuses on several important aspects of PAH management, including a discussion of the challenges diagnosing and treating patients, clinical trial data on emerging therapeutics for the management of PAH, and a review of strategies to optimize outcomes for patients with PAH. FACULTY Aaron Waxman, MD, PhD, FACP, FCCP Director, Pulmonary Vascular Disease Program Executive Director, Center for Pulmonary Heart Diseases Brigham and Women's Hospital, Heart and Vascular Center Mardi Gomberg-Maitland, MD, MSc Chief Research Officer George Washington Office of Clinical Research Director, Pulmonary Hypertension George Washington University School of Medicine and Health Sciences Review the activity at 🤍 and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation. This activity is provided in collaboration with Rush University Medical Center and Practice Point Communications Supported by independent educational grants from Merck Sharp & Dohme LLC a subsidiary of Merck & Co., Inc.
While personal treatment goals for pulmonary arterial hypertension (PAH) patients may seem different from a physician’s, they actually work in harmony. Terms such as “risk status” and “functional class” may sound intimidating at first, but they are important tools to help you and your doctor achieve your treatment goals. In this video, PAH expert Dr. Lana Melendres-Groves will discuss the importance of PAH treatment goals for both patients and physicians, and the importance of communicating your goals to your doctor. Visit PAHinitiative.com to download your doctor discussion guide today.
Meet Jane, Rosie, and Sandra. They all live with pulmonary arterial hypertension (PAH), a rare form of pulmonary hypertension (PH), and share their personal stories in this video. Jane, Rosie, and Sandra have all had different experiences of living with PAH. In this video we hear about their unique paths to their PAH diagnoses, and helpful recommendations on how to adapt to managing their condition. To hear more personal stories from people living with PAH, visit our PH Human website: 🤍 What is PH? Pulmonary hypertension (PH) is high pressure in the blood vessels of the lungs, as the right side of the heart has to work harder to pump blood through the lungs.1,2 It is a serious, progressive disease and can lead to heart failure and early death.3,4 Pulmonary arterial hypertension (PAH) is a progressive, rare type of PH that affects the blood vessels that carry blood from the heart to the lungs.2,5 These are known as pulmonary arteries.2,5 Over time, the pulmonary arteries become increasingly narrow, as the walls of the blood vessels become thicker and less flexible.2,5 This restricts blood flow to the lungs, which makes it harder for the heart to pump blood through the arteries.6 Trying to maintain the blood flow, the heart has to pump harder, increasing the pressure in the pulmonary arteries.6 Due to the rarity of PAH and the non-specific nature of its symptoms, PAH can be confused with more common conditions such as chronic obstructive pulmonary disease (COPD).3,4 References 1. Galiè N, Humbert M, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016;37:67–119. 2. Lai Y, Potoka KC, et al. Pulmonary arterial hypertension: The clinical syndrome. Circ Res 2014;115:115–30. 3. Vachiéry JL and Gaine S. Challenges in the diagnosis and treatment of pulmonary arterial hypertension. Eur Respir Rev 2012;21:313–20. 4. Hoeper MM and Gibbs SR. The changing landscape of pulmonary arterial hypertension and implications for patient care. Eur Respir Rev 2014;23:450–7. 5. Schermuly RT, Ghofrani HA, et al. Mechanisms of disease: Pulmonary arterial hypertension. Nat Rev Cardiol 2011;8:443–55. 6. National Organisation of Rare Diseases (2019). Rare Disease Database: Pulmonary Arterial Hypertension. Available at: 🤍
Not many people have heard of Pulmonary Arterial Hypertension (PAH), but Kathryn has been living with it since 2006. Though it's a serious condition, she doesn't let it slow her down - not even on the tennis court!
PULMONARY ARTERIAL HYPERTENSION OR PAH IS A CHRONIC AND PROGRESSIVE RARE DISEASE THAT AFFECTS YOUR HEART’S ABILITY TO PUMP BLOOD TO YOUR LUNGS. The Balancing Act goes Behind the Mystery of Pulmonary Arterial Hypertension (PAH). PAH can eventually lead to heart failure, and ultimately, death, but treatment may delay the disease from getting worse, which is why awareness for this rare disease is so important. The Balancing Act host Olga Villaverde sits down with pulmonologist Dr. Lana Melendres-Groves and Marla, a patient with PAH, to learn more about the disease and its effects on patients. Due to the progressive nature of PAH, it’s vital that patients stay vigilant with how they are feeling and to communicate with their physician; and for doctors to continue to assess a patient’s risk for disease progression. Management of PAH may include lifestyle changes and adding additional therapies to a treatment regimen. It’s important to stay ahead of the disease; even if symptoms don’t seem to be getting worse, always talk to your doctor to make sure your treatment plan is still right for you. Visit: 🤍 Like: 🤍 Follow: 🤍 #TheBalancingAct #BalancingAct 105254
This animation demonstrates the basic functioning of a human heart and the condition, PAH (Pulmonary Arterial Hypertension). The heart works as a pump; with each heart beat, blood is pumped around the body carrying oxygen and nutrients to body tissue. PAH is caused by a problem with the pulmonary arteries; they become narrower and the amount of blood that can flow through them is reduced. Contact Us: Website: 🤍 Facebook: 🤍 Email: studio🤍medical-animations.com Medical Animations: 🤍 © 2015 Animated Biomedical Productions
Pulmonal arterielle Hypertonie, kurz PAH, ist eine spezielle Form des Lungenhochdrucks. Diese seltene und schwere Erkrankung betrifft sowohl das Herz als auch die Lunge. Prof. Dr. med. Ekkehard Grüning (Thoraxklinik, Universitätsklinikum Heidelberg) und Prof. Dr. Dr. med Harald Kaemmerer (Deutsches Herzzentrum München) erklären, welche Symptome bei PAH auftreten und warum eine schnelle Diagnose für Patient:innen überlebenswichtig ist. Weitere Informationen zum Thema Lungenhochdruck unter 🤍 EM-121278
When you have pulmonary arterial hypertension (PAH), your goals likely involve wanting to feel better so that you can do more in life. Learn more about the science behind PAH symptoms and things to consider with your healthcare team if your symptoms are not well controlled. In this PAH Today broadcast, you’ll hear from nationally recognized PAH healthcare provider Dr. Lana Melendres-Groves. She will explain how what is happening in the lungs and heart can lead to symptoms that affect your whole body. She will also discuss ways to possibly get ahead of future symptoms and things to consider with your doctor if your symptoms are not improving.
Dr Greg Kier provides a snapshot of Pulmonary Arterial Hypertension, what it is and highlights the symptoms, diagnosis and treatment.
The Pulmonary Arterial Hypertension (PAH) Patient Charter outlines the standards of holistic care that you should expect to receive. This includes having access to holistic care and support. Professor Susanna Proudman explains what holistic care is, what you should expect from your ongoing care and what steps you can take if you feel you're not getting the most out of your treatment and care. Lung Foundation Australia offers resources, information, support services and programs for people living with PAH and Pulmonary Hypertension. You can download a free resource and information pack, which includes the PAH Patient Charter, via the website here: 🤍
Roxana Sulica, MD, Associate Professor, Department of Medicine and Director, Pulmonary Hypertension at NYU Langone in New York City discusses the current tretment options of pulmonary arterial hypertension (PAH), a progressive condition that affects the heart and lungs. PAH is characterized by abnormally high blood pressure (hypertension) in the pulmonary artery, the blood vessel that carries blood from the heart to the lungs. The most common signs and symptoms are shortness of breath (dyspnea) during exertion and fainting spells. As the condition worsens, people can experience dizziness, swelling (edema) of the ankles or legs, chest pain, and a racing pulse. Most cases of PAH occur in individuals with no family history of the disorder. Although some cases are due to mutations in the BMPR2 gene and inherited in an autosomal dominant pattern, a gene mutation has not yet been identified in most individuals. When PAH is inherited from an affected relative it is called "familial" PAH. Cases with no identifiable cause may be referred to as "idiopathic" PAH. PAH can also occur secondary to an underlying disorder such as connective tissue diseases, HIV infection, chronic hemolytic anemia, and congenital heart disease, to name a few. PAH can also be induced by certain drugs and toxins, for example fenfluramine and dexfenfluramine (appetite suppressants now banned by the FDA), toxic rapeseed oil, and amphetamines.
This time around, Nameless collaborates with prolific Tanzanian rapper Darassa to bring you PAH, an easy mid-tempo love song with a strong East African vibe. In this video, Nameless also takes the opportunity to introduce us to his newly unveiled Brand Icon. PAH written and performed by Nameless and Darassa produced by Bern Mziki Co-Arranged by Ihaji mixed and mastered by Lucas 🤍Ogopathereal video by HansScana Digital Distribution & Promotions: Ziiki Media. Nameless Icon Nameless icon Designed by Arnold Lakhita Icon animated by AMP
Do you know what pulmonary arterial hypertension (PAH) treatment guidelines are and how they guide your doctor’s recommendations? It’s empowering to better understand what the guidelines say about when to consider making a change to your treatment plan. The right combination of treatments may help improve PAH symptoms, slow disease progression, and help you do more in your day. Talk with your doctor about available types of medicines and finding the right combination for you. In this video, pulmonary expert Dr. Sean M. Studer shares how PAH treatment guidelines help your healthcare team stay on top of advances in care and ensure that those living with PAH receive consistent, effective care. Visit PAHInitiative.com to learn more about PAH treatment guidelines and treatment pathways.
#hypertension #mechanismofhypertension #hypertensive #cardiology,cardiacsystem #hypertensivedisorder #essentialhypertension #secondaryhypertension #bloodpressurehighbloodpressure #lowbloodpressure #bloodpressurecontrol #bloodpressureexplained#normalbloodpressure Valsad:-Gujarat Agrawal superspeciality clinic Yashkamal building block A first floor, opposite jade blue showroom Tithal Road,Valsad, Gujarat(india)395001 Timings:-9:00-10:30 in morning on Monday to Friday and 3:30pm to 5:30 pm in afternoon Daily(Excluding Sunday) Admission and emergency patients and cardiac intervention at Valsad are performed at ZENITH DOCTOR HOUSE,(ADARASH HOSPITAL)Near post office and Ava bai school, Halar road, Valsad For appointment:- 02632-356091 9316799267 INSTAGRAM-DR NAVIN AGRAWAL FACEBOOK- DR NAVIN AGRAWAL
#pulmonaryhypertension #pulmonaryhypertensionHindi #pulmonaryhypertensionCauses #pulmonaryhypertensionSymptoms #PulmonaryhypertensionDiagnosis #pulmonaryhypertensionRiskFactors #pulmonaryhypertensionTreatment #PAH #pulmonaryhypertensiontreatmentHindi Hello friends, In this video we have discussed about Pulmonary Hypertension or PAH and all its ralated aspects to make it understand for everyone. Comments will be answered. For Teleconsultation our Whatsapp Number is 9763287676. Please dont call directly. For Free Medical Advice kindly join our Telegram Group. You will receive the group joining link after messeging on our Whatsapp number. Answer to all queries about Gangrene is in following playlist Gangrene Playlist 🤍 Most watched videos of our channel in this playlist Most Watched 🤍 Some Useful Gadgets For Patients: 1. Health monitoring smart watch 🤍 2. Digital Blood pressure monitor: 🤍 3. Digital thermometer:🤍 4. Pulseoximeter:🤍 5. Sugar checking machine:🤍 6. Hair growth tonic🤍 7. Nebuliser machine:🤍 8. Spirometer for lung excercise:🤍 9. Oxygen Concentrator:🤍 10. N95 Masks 🤍 11. Infrared Thermometer🤍 Explained in simple language by professional doctor with reference from Medical library and latest research meta analysis. Dr.K.S.Chougule is highly recommended full family physician who is known for his passion and dedication to LISTEN,TREAT and EDUCATE his patients on their health concerns. Experience: 1 year in medical ICU (Govt.hospital, Kolhapur) 1year in Emergency and casuality. 4 months each in Medicine , Surgery and Neurology. Currently working at Matru krupa Hospital , Ratnagiri, Maharastra. Thanks and Regards, Dr.K.S.Chougule. BAMS, MD. Post graduate diploma in emergency medicine. Post graduate diploma in geriatric medicine. Disclaimer: Any photographs or music or graphs or images used in this video are purely for educational purpose and there is NO any kind of violation of rules or regulations is intended. This information is intended as patient education only and should not be used for diagnosing and treating health problems. As it is not A substitute for professional medical care. We reccomend you guidance from your local physician before application of information in this video. Follow us on Twitter- 🤍 Facebook - 🤍 LinkedIn 🤍 Instagram 🤍 #Onlinedoctorconsultation #Onlineconsultation #Onlinedoctor #Onlinetreatment #drkschougule #doctor #health #besttreatment #hindiconsultations #wellness #bestdoctor Email dr.k.s.chougule1995🤍gmail.com
It’s hard to know what PAH medications are right for you. Hearing about others’ experiences and knowing all your options are good places to start. In this short video, Laura, Peggy, and Karen share their stories—their successes AND challenges—taking a prostacyclin-class medication as part of their pulmonary arterial hypertension (PAH) treatment plan. Learn more about prostacyclin-class treatment and talk to your Doctor. PAHInitiative.com
Ziel der Therapie einer pulmonal arteriellen Hypertonie (PAH) ist es, dass Patient:innen ein Leben so normal wie möglich führen können. Im Austausch mit Arzt oder Ärztin sollte der individuell beste therapeutische Ansatz gefunden werden. Dazu zählt in der Regel eine frühzeitige medikamentöse Behandlung, oft mit mehreren Arzneimitteln in Kombination. Nähere Infos unter: 🤍 EM-89324/EM-121278
Do you have pulmonary arterial hypertension (PAH) and as your healthcare provider suggested that you begin an exercise routine? Here’s a great place to begin. Follow along with this short arms strength video that will leave you feeling energized. Feel free to push “pause” at any point if you need to rest or take a water break. Visit PAHInitiative.com for more 6-minute PHitness videos and other information about living with PAH.
The clearance of creatinine is approximately equal to GFR, but not exactly inulin is more exact. PAH, meanwhile, is totally secreted, which means its clearance is equal to RPF (renal plasma flow). For more videos and questions, visit - 🤍. Subscribe - 🤍 Support us on Patreon - 🤍 In addition to creating open-access educational videos like this one, Macrophage offers a free cutting-edge edge learning platform for medical education. We use short videos, questions, and machine learning to adapt our courses to your specific strengths and weaknesses. Make a free account at 🤍 🤍 Subscribe to our channel - 🤍 Support us on Patreon - 🤍
Pulmonary arterial hypertension (PAH) is a condition of high lung pressure in the blood vessels leading from the heart to the lung. It can affect anyone of any age, sex or race. However, it is more common in women aged between 30 and 50 years old. In this clip, learn about the common symptoms of PAH, its subgroups, the condition's association with connective tissue diseases (CTDs) and treatment options for PAH. This video was brought to you by the National Heart Centre Singapore (NHCS) in partnership with the Singapore General Hospital (SGH), both members of the SingHealth group.
Earn CME: 🤍 © 2021 NACCME, an HMP Company
With pulmonary arterial hypertension (PAH), changes in your heart are happening before you notice changes in your symptoms. Dr. Lana Melendres-Grove explains how PAH specialists use the echocardiogram (Echo) as a noninvasive test to monitor changes in the right heart, helping your doctor be more proactive and try to prevent PAH symptoms before they happen. Presenter: Lana Melendres-Groves, MD Medical Director, Pulmonary Hypertension Program University of New Mexico
Memorial Şişli Hastanesi Kardiyoloji Bölümü'nden Doç. Dr. Hatice Betül Erer, pulmoner arteriyel hipertansiyon (PAH) nasıl tedavi edilir? sorusuna yanıt veriyor.
Find out more about Visual Storytelling: 🤍 Bringing physicians aboard – Education for investigators A biotech startup contacted CAST PHARMA with the need for an educational video to convince physicians to take part in a clinical study and to give them all necessary information. The new medication was being developed for the treatment of pulmonary arterial hypertension (PAH), a rare disease characterized by elevated pressure in the pulmonary arteries. We created an audio-visual tool focusing on the right heart catheter (RHC) as the gold standard for diagnosis and assessment of PAH. To read the full case study, click here: 🤍
.svg){kind=small}
